BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23755307)

  • 1. Decreased tumor progression and invasion by a novel anti-cell motility target for human colorectal carcinoma cells.
    Jin Q; Liu G; Domeier PP; Ding W; Mulder KM
    PLoS One; 2013; 8(6):e66439. PubMed ID: 23755307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TGFβ receptor-interacting protein km23-1/DYNLRB1 plays an adaptor role in TGFβ1 autoinduction via its association with Ras.
    Jin Q; Ding W; Mulder KM
    J Biol Chem; 2012 Jul; 287(31):26453-63. PubMed ID: 22637579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Fos is required for TGFbeta1 production and the associated paracrine migratory effects of human colon carcinoma cells.
    Liu G; Ding W; Liu X; Mulder KM
    Mol Carcinog; 2006 Aug; 45(8):582-93. PubMed ID: 16637060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezrin expression and cell survival regulation in colorectal cancer.
    Leiphrakpam PD; Rajput A; Mathiesen M; Agarwal E; Lazenby AJ; Are C; Brattain MG; Chowdhury S
    Cell Signal; 2014 May; 26(5):868-79. PubMed ID: 24462708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgelin is a poor prognostic factor associated with advanced colorectal cancer (CRC) stage promoting tumor growth and migration in a TGFβ-dependent manner.
    Elsafadi M; Manikandan M; Almalki S; Mahmood A; Shinwari T; Vishnubalaji R; Mobarak M; Alfayez M; Aldahmash A; Kassem M; Alajez NM
    Cell Death Dis; 2020 May; 11(5):341. PubMed ID: 32393769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-invasive effect and pharmacological mechanism of genistein against colorectal cancer.
    Chen X; Wu Y; Gu J; Liang P; Shen M; Xi J; Qin J
    Biofactors; 2020 Jul; 46(4):620-628. PubMed ID: 32078221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. km23-1/DYNLRB1 regulation of MEK/ERK signaling and R-Ras in invasive human colorectal cancer cells.
    Raza A; Pandey MS; Jin Q; Mulder KM
    Cell Biol Int; 2020 Jan; 44(1):155-165. PubMed ID: 31393067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
    Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer.
    Ye Q; Cai W; Zheng Y; Evers BM; She QB
    Oncogene; 2014 Apr; 33(14):1828-39. PubMed ID: 23624914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β1 regulates the invasive and metastatic potential of mucoepidermoid carcinoma cells.
    Wang J; Chen J; Zhang K; Zhao Y; Nör JE; Wu J
    J Oral Pathol Med; 2011 Nov; 40(10):762-8. PubMed ID: 21689159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis.
    Bergeron S; Lemieux E; Durand V; Cagnol S; Carrier JC; Lussier JG; Boucher MJ; Rivard N
    Mol Cancer; 2010 Oct; 9():271. PubMed ID: 20942929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of km23-1 in RhoA/actin-based cell migration.
    Jin Q; Pulipati NR; Zhou W; Staub CM; Liotta LA; Mulder KM
    Biochem Biophys Res Commun; 2012 Nov; 428(3):333-8. PubMed ID: 23079622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
    Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
    Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways.
    Tian XY; Li J; Liu TH; Li DN; Wang JJ; Zhang H; Deng ZL; Chen FJ; Cai JP
    Cancer Med; 2020 Nov; 9(22):8612-8623. PubMed ID: 33016643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
    Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway.
    Hsu YL; Hou MF; Kuo PL; Huang YF; Tsai EM
    Oncogene; 2013 Sep; 32(37):4436-47. PubMed ID: 23045282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways.
    Zhao J; Ou B; Han D; Wang P; Zong Y; Zhu C; Liu D; Zheng M; Sun J; Feng H; Lu A
    Mol Cancer; 2017 Mar; 16(1):70. PubMed ID: 28356111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.